Vu Truong
Chief Executive Officer bij ARIDIS PHARMACEUTICALS, INC.
Vermogen: 57 514 $ op 31-03-2024
Actieve functies van Vu Truong
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ARIDIS PHARMACEUTICALS, INC. | Director/Board Member | 01-01-2003 | - |
Chief Executive Officer | 01-01-2014 | - | |
Chief Tech/Sci/R&D Officer | 01-01-2005 | - | |
Founder | 01-01-2003 | - |
Loopbaan van Vu Truong
Eerdere bekende functies van Vu Truong
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - | - |
Opleiding van Vu Truong
Brandeis University | Undergraduate Degree |
The Johns Hopkins University | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ARIDIS PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |